These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant. Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C Front Immunol; 2019; 10():1208. PubMed ID: 31249568 [TBL] [Abstract][Full Text] [Related]
11. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study. Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794 [TBL] [Abstract][Full Text] [Related]
12. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation. Viglietti D; Lefaucheur C; Glotz D Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472 [TBL] [Abstract][Full Text] [Related]
14. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients. Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460 [TBL] [Abstract][Full Text] [Related]
15. Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal. Al-Awadhi S; Raynaud M; Louis K; Bouquegneau A; Taupin JL; Aubert O; Loupy A; Lefaucheur C Front Immunol; 2023; 14():1265796. PubMed ID: 37849755 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients. Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941 [TBL] [Abstract][Full Text] [Related]
17. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173 [TBL] [Abstract][Full Text] [Related]
18. A diagnostic 'C' saw: the ups and downs of C1q testing. Gebel HM; Bray RA Curr Opin Organ Transplant; 2019 Aug; 24(4):402-410. PubMed ID: 31135562 [TBL] [Abstract][Full Text] [Related]
19. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. Koenig A; Mezaache S; Callemeyn J; Barba T; Mathias V; Sicard A; Charreau B; Rabeyrin M; Dijoud F; Picard C; Meas-Yedid V; Olivo-Marin JC; Morelon E; Naesens M; Dubois V; Thaunat O J Am Soc Nephrol; 2021 Feb; 32(2):479-494. PubMed ID: 33239394 [TBL] [Abstract][Full Text] [Related]
20. [Role of antibodies in kidney transplant]. Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]